News | Stent Grafts
PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) trial of the companyโs Torus stent graft. The novel stent graft platform is designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). By acquiring early U.S. Food and Drug Administration (FDA) feedback through the pre-submission process, the TORUS-2 study (The PQ Bypass pivOtal IDE intra-aRterial stent graft study for occlUsive and re-Stenotic fem-pop revascularization) is the companyโs second IDE approved in less than two years and is the first pivotal IDE for an SFA stent graft since Viabahn received initial premarket approval (PMA) in 2005.
October 08, 2019
American Heart Association President Robert Harrington, M.D., explains the reasons for shorter duration dual-antiplatelet therapy (DAPT) in high-risk bleeding patient
October 08, 2019
Videos | Cardiogenic Shock
William OโNeill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, explains data on first 250 patients in the National Cardiogenic Shock Initiative Study (NCSI) and new escalation protocols
October 08, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
360 Photos | 360 View Photos
Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its ...
October 08, 2019
Feature | Sudden Cardiac Arrest
October 7, 2019 โ Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July ...
October 07, 2019
October 7, 2019 โ A recent study published in the New England Journal of Medicine supports the use of cardiac magnetic ...
October 07, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Videos | TCT
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...
October 04, 2019
News | Heart Valve Technology
October 4, 2019 โ A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...
October 04, 2019
News | Heart Failure
October 4, 2019 โ Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 04, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
October 4, 2019 โ RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
October 04, 2019
News | Heart Valve Technology
October 3, 2019 โ Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...
October 03, 2019
Feature | Cath Lab
October 3, 2019 โ Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 03, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Failure
October 3, 2019 โ The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 03, 2019
News | Heart Valve Technology
October 2, 2019 โ The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate neo ...
October 02, 2019
Videos | University of Colorado Hospital
Interview with John Carroll, M.D., director of interventional cardiology, Robert Quaife, M.D., director of advanced ...
October 02, 2019ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now